Invesco
RXII

Invesco’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Invesco’s Portfolio RXII Stock Details RXII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-2,843
Closed -$5K – 4297
2015
Q2 		$5K Buy
+2,843
New +$5K ﹤0.01% 4268
2014
Q3 		– Sell
-386,210
Closed -$1.18M – 4184
2014
Q2 		$1.18M Buy
+386,210
New +$1.18M ﹤0.01% 2915

Other funds holding RXII

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Invesco's RXII Position: Q3 2015 in Review

Invesco sold out of GALENA BIOPHARMA INC COM (RXII) in Q3 2015, closing a stake of 2,843 shares — an estimated $5K sold.

Invesco first reported a position in RXII in Q2 2014 and held it in 2 quarters. The position peaked at $1.18M in Q2 2014. 78 funds tracked by Wall St. Rank hold RXII as of Q3 2015.

  • Invesco reported no remaining GALENA BIOPHARMA INC COM position as of Q3 2015 after selling out during the quarter.
  • Invesco sold 2,843 GALENA BIOPHARMA INC COM shares in Q3 2015, an estimated $5K.
  • Invesco first reported a position in GALENA BIOPHARMA INC COM in Q2 2014 and held it in 2 quarters.
  • Invesco's GALENA BIOPHARMA INC COM position peaked at $1.18M in Q2 2014.
  • 78 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q3 2015.

Based on Invesco's 13F filing for Q3 2015, filed 16 Nov 2015.